What was Oncology Pharma’s price range in the past 12 months?
Oncology Pharma lowest stock price was $0.01 and its highest was $0.36 in the past 12 months.
What is Oncology Pharma’s market cap?
Oncology Pharma’s market cap is $1.10M.
When is Oncology Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Oncology Pharma overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Oncology Pharma pay dividends?
Oncology Pharma does not currently pay dividends.
What is Oncology Pharma’s EPS estimate?
Oncology Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncology Pharma have?
Oncology Pharma has 27,388,216 shares outstanding.
Which hedge fund is a major shareholder of Oncology Pharma?
Currently, no hedge funds are holding shares in ONPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Oncology Pharma
Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019. Its operations are based in San Francisco, California.